ASCO 2024 results of a multicenter phase II trial of modified FOLFIRINOX for the first-line treatment of advanced urachal cancer (ULTMA; KCSG GU20-03), Urachal cancer is a rare malignancy accounting for 1% of bladder cancers.
The Ambrose Alli University College of Medicine Alumni Association (AAUCOMAA) has asked Governor Godwin Obaseki of Edo State to stop the school from forcing medical students of the University to sign a controversial undertaking. SaharaReporters reported on Wednesday that the University's College of Medicine had reportedly compelled 300-level Medicine and Surgery students to sign an undertaking to continue to pay school fees for an additional 18-month programme while awaiting available slots to progress to 400-level.